These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 4121844)

  • 1. Effect of steroidal contraceptives on levels of plasma androgen sulphates and cortisol.
    Bulbrook RD; Herian M; Tong D; Hayward JL; Swain MC; Wang DY
    Lancet; 1973 Mar; 1(7804):628-31. PubMed ID: 4121844
    [No Abstract]   [Full Text] [Related]  

  • 2. Relation between plasma-cortisol, plasma-androgen-sulphates, and immune response in women with breast cancer.
    Mackay WD; Bulbrook RD; Wang DY; Edwards MH
    Lancet; 1971 Nov; 2(7732):1001-2. PubMed ID: 4108064
    [No Abstract]   [Full Text] [Related]  

  • 3. Estrogens, progestogens and breast cancer.
    Sturgis SH
    N Engl J Med; 1969 Oct; 281(18):1014-5. PubMed ID: 5824728
    [No Abstract]   [Full Text] [Related]  

  • 4. Morphologic features of mammary carcinomas in women taking hormonal contraceptives.
    Gould VE; Wolff M; Mottet NK
    Am J Clin Pathol; 1972 Feb; 57(2):139-43. PubMed ID: 4333281
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum dehydroepiandrosterone, androsterone and cortisol level in primary postmenopausal and other type osteoporosis.
    Holló I; Fehér T; Szücs J
    Acta Med Acad Sci Hung; 1970; 27(2):155-60. PubMed ID: 4248799
    [No Abstract]   [Full Text] [Related]  

  • 6. Routine clinical determination of testosterone in plasma by competitive-protein-binding.
    Dessypris A; Adlercreutz H
    J Steroid Biochem; 1972 Jan; 3(1):19-30. PubMed ID: 4262878
    [No Abstract]   [Full Text] [Related]  

  • 7. [On steroid conjugates in plasma. XIV. On the binding of sulfo-conjugated steroids to plasma proteins].
    Oertel GW; Groot K; Brühl P
    Hoppe Seylers Z Physiol Chem; 1965; 341(1):10-21. PubMed ID: 4225855
    [No Abstract]   [Full Text] [Related]  

  • 8. Experimental and clinical aspects of the carcinogenic potential of steroid contraceptives.
    Hertz R
    Int J Fertil; 1968; 13(4):273-86. PubMed ID: 4882601
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasma dehydroepiandrosterone and androsterone sulphates, androstenedione and urinary androgen metabolites in normal British and Japanese women.
    Wang DY; Hayward JL; Bulbrook RD; Kumaoka S; Takatani O; Abe O; Utsunomiya J
    Eur J Cancer (1965); 1976 Dec; 12(12):951-8. PubMed ID: 137812
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasma steroids and nasopharyngeal carcinoma.
    Shanmugaratnam K; Goh EH; Herian M; Bulbrook RD; Wang DY
    Singapore Med J; 1974 Dec; 15(4):257-60. PubMed ID: 4281934
    [No Abstract]   [Full Text] [Related]  

  • 11. [Oral contraception: uncertainties and prospects].
    Mauvais-Jarvis P
    Rev Prat; 1978 Sep; 28(41):3143-6, 3149-50, 3153-6. PubMed ID: 715351
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma dehydroepiandrosterone, dehydroepiandrosterone sulphate and androsterone sulphate levels and their interaction with plasma proteins in rheumatoid arthritis.
    Fehér KG; Fehér T
    Exp Clin Endocrinol; 1984 Oct; 84(2):197-202. PubMed ID: 6241153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excretion of urinary 17-hydroxycorticosteroids and 11-deoxy-17-oxosteroids by women using steroidal contraceptives.
    Bulbrook RD; Hayward JL
    Lancet; 1969 Nov; 2(7629):1033-5. PubMed ID: 4187543
    [No Abstract]   [Full Text] [Related]  

  • 14. [The mechanism of action of oral contraceptives].
    Manuilova IA
    Akush Ginekol (Mosk); 1971 Feb; 47(2):3-8. PubMed ID: 4940751
    [No Abstract]   [Full Text] [Related]  

  • 15. [Oral contraceptives and menopausal estrogens in relation to breast neoplasia].
    Brzezinski A; Schenker JG
    Harefuah; 1983 Jun; 104(11-12):520-3. PubMed ID: 6680711
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on the sulphate esters of dehydroepiandrosterone and androsterone in the blood of women with breast cancer.
    Wang DY; Bulbrook RD; Herian M; Hayward JL
    Eur J Cancer (1965); 1974 Aug; 10(8):477-82. PubMed ID: 4282478
    [No Abstract]   [Full Text] [Related]  

  • 17. Endometrial cancer with progestagen and oestrogen oral contraceptives.
    Grant ECG
    Lancet Oncol; 2015 Nov; 16(15):e527. PubMed ID: 26545838
    [No Abstract]   [Full Text] [Related]  

  • 18. Possible hazards in estrogen administration.
    Allen W
    Cancer; 1969 Dec; 24(6):1137-9. PubMed ID: 5353958
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma cortisol after one to sixty cycles of oral contraception.
    Williamson HO; Moody LO
    J Reprod Med; 1970 Jul; 5(1):9-12. PubMed ID: 5521772
    [No Abstract]   [Full Text] [Related]  

  • 20. Conjugated and unconjugated dehydroepiandrosterone, aetiocholanolone and androsterone in the peripheral plasma of patients with cancer of the breast, ovary, uterus or prostate.
    Garnham JR; Bulbrook RD; Wang DY
    Eur J Cancer (1965); 1969 Jun; 5(3):239-45. PubMed ID: 4239549
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.